Effect of weight loss and nutritional intervention on arterial stiffness in type 2 diabetes

Diabetes Care

Volumn 29, Issue 10, 2006, Pages 2218-2222

  Barinas Mitchell, Emma ^a   Kuller, Lewis H ^a   Sutton Tyrrell, Kim ^a   Hegazi, Refaat ^a   Harper, Patricia ^a   Mancino, Juliet ^a   Kelley, David E ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; TETRAHYDROLIPSTATIN; TUMOR NECROSIS FACTOR ALPHA;

ARTERY DISEASE; ARTERY STIFFNESS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; HUMAN; INSULIN RESISTANCE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PULSE WAVE; WEIGHT REDUCTION;

ADULT; AGED; C-REACTIVE PROTEIN; CAROTID ARTERY, COMMON; DIABETES MELLITUS, TYPE 2; ELASTICITY; FEMALE; FEMORAL ARTERY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PULSATILE FLOW; PULSE; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY, DOPPLER; WEIGHT LOSS;

EID: 33845424579     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0665     Document Type: Article

References (31)

1. Gu K, Cowie C, Harris M: Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 21:1138-1145, 1998
2. Asmar R, Rudnichi A, Blacher J, London G, Safar M: Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. Am J Hypertens 14:91-97, 2001
3. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:1236-1241, 2001
4. Safar M: Pulse pressure, arterial stiffness, and cardiovascular risk. Curr Opin Cardiol 15:258-263, 2000
5. Cruickshank K, Riste L, Anderson S, Wright J, Dunn G, Gosling R: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance. Circulation 106:2085-2090, 2002
6. Sutton-Tyrrel K, Najjar S, Boudreau R, Venkitachalam L, Kupelian V, Simonsick E, Havlik R, Lakatta E, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A, the Health ABC Study: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111:3384-3390, 2005
7. Safar M: Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 10:257-261, 2001
8. Tsuchiya M, Suzuki E, Egawa K, Nishio Y, Maegawa H, Inoue S, Mitsunami K, Morikawa S, Inubushi T, Kashiwagi A: Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patients. Diabetes Care 27:2409-2415, 2004
9. Lakatta E: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 107:490-497, 2003
10. Bots M, Dijk J, Oren A, Grobbee D: Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 20:2317-2325, 2002
11. Sutton-Tyrrell K, Newman A, Simonsick E, Havlik R, Pahor M, Lakatta E, Spurgeon H, Vaitkevicius P: Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 38:429-433, 2001
12. Aoun S, Blacher J, Safar M, Mourad J: Diabetes mellitus and renal failure: effects on large artery stiffness. J Hum Hypertens 15:693-700, 2001
13. Ohnishi H, Saitoh S, Takagi S, Ohata J-I, Isobe T, Kikuchi Y, Takeuchi H, Shimamoto K: Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose. Diabetes Care 26:437-440, 2003
14. Salomaa V, Riley W, Kark J, Nardo C, Folsom A: Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC Study: Atherosclerosis Risk in Communities Study. Circulation 91:1432-1443, 1995
15. Schram Mea: Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 43:176-181, 2004
16. van Dijk R, Dekker J, Nijpels G, Heine R, Bouter L, Stehouwer C: Brachial artery pulse pressure and common carotid artery diameter: mutually independent associations with mortality in subjects with a recent history of impaired glucose tolerance. Eur J Clin Invest 31:756-763, 2001
17. Hegazi R, Sutton-Tyrrell K, Evans R, Kuller L, Belle S, Yamamoto M, Edmundowicz D, Kelley D: Relationship of adiposity to subclinical atherosclerosis in obese patients with type 2 diabetes. Obes Res 11:1597-1605, 2003
18. Taquet A, Bonithon-Kopp C, Simon A, Levenson J, Scarabin MA, Ducimetiere P, Guize L: Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol 9:298-306, 1993
19. Wildman R, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrel K: Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 42:468-473, 2003
20. Gungor N, Thompson T, Sutton-Tyrrell K, Janosky J, Arslanian S: Early signs of cardiovascular disease in youth with obesity and type 2 diabetes. Diabetes Care 28: 1219-1221, 2005
21. Woodman R, Chew G, Watts G: Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy. Drugs 65:31-74, 2005
22. Wildman R, Farhat G, Patel A, Mackey R, Brockwell S, Thompson T, Sutton-Tyrrell K: Weight change is associated with change in arterial stiffness among healthy young adults. Hypertension 45:187-192, 2005
23. Kelley D, Kuller L, McKolanis T, Harper P, Mancino J, Kalhan S: Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes. Diabetes Care 27: 33-40, 2004
24. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH: Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol 278:E941-E948, 2000
25. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M, the American Diabetes Association: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (Position Statement). Diabetes Care 25 (Suppl. 1): S50-S60, 2002
26. Clauss A: [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haemost 17:237-246, 1957 [article in German]
27. Macy E, Hayes T, Tracy R: Variability in the measurement of C-reactive protein in healthy subjects: implications for reference interval and epidemiological applications. Clin Chem 43:52-58, 1997
28. Macy E, Meilahn E, DeClerck P, Tracy R: Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies. Arch Path Lab Med 177:67-70, 1993
29. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, Quon MJ, Baron AD: Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 86:5457-5464, 2001
30. Ryan DH, Espeland MA, Foster GD, Haffner SM, Hubbard VS, Johnson KC, Kahn SE, Knowler WC, Yanovski SZ, the Look AHEAD Research Group: Design and methods for a clinical trial weight loss prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 24:610-628, 2003
31. Wing R, Koeske R, Epstein L, Nowalk M, Gooding W, Becker D: Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 147:1749-1753, 1987